flow trial semaglutide kidney outcomes 2024 nejm hazard ratio ❇️Patients with obesity, type 2 #diabetes and chronic disease are at high risk for kidney failure, cardiovascular events, and death. This study, the now published, evaluated treatment with (# Semaglutide: The Drug of Today

Rare patients experience minor, temporary triglyceride elevations during initial weeks, but these typically resolve as the body adjusts

These differences were small enough that they didnt break statistical significance

This is the new standard for modern telehealth weight loss programs USA

A 54-year-old woman with type 2 diabetes and sleep apnea started semaglutide

People with specific thyroid cancer histories are advised against these medications as a safety measure

However, the adverse effects may begin to manifest quickly, such as decreased appetite and occasionally difficult sleep (but dont let that stop you from using it!)